Select Medical Holdings Corp (NYSE: SEM)

Sector: Healthcare Industry: Medical Care Facilities CIK: 0001320414
Market Cap 1.88 Bn
P/B 1.11
P/E 17.06
P/S 0.48
ROIC (Qtr) 0.75
Div Yield % 2.51
Rev 1y % (Qtr) 7.22
Total Debt (Qtr) 2.77 Bn
Debt/Equity (Qtr) 1.64

About

Select Medical Holdings Corp, also known as SEM, is a prominent player in the healthcare industry, specializing in the operation of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. Established in 1997, the company's headquarters are located in Brentwood, Tennessee. SELECT MEDICAL HOLDINGS CORP's primary business activities revolve around the provision of specialized healthcare services, including physical, occupational, and speech rehabilitation...

Read more

Price action

Investment thesis

Bull case

  • Strong operating cash flow of 407.57M provides 2.16x coverage of SG&A expenses 188.92M, showing efficient operational cost management.
  • Operating cash flow of 407.57M fully covers other non-current liabilities 164.33M by 2.48x, showing strong long-term stability.
  • Robust tangible asset base of 3.25B provides 40.19x coverage of working capital 80.89M, indicating strong operational backing.
  • Tangible assets of 3.25B provide robust 5.81x coverage of other current liabilities 559.48M, indicating strong asset backing.
  • Operating cash flow of 407.57M provides strong 4.62x coverage of tax liabilities 88.31M, showing excellent fiscal position.

Bear case

  • Operating cash flow of 407.57M barely covers its investment activities of (223.79M), with a coverage ratio of -1.82, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Operating cash flow of 407.57M provides thin coverage of dividend payments of (39.81M) with a -10.24 ratio, suggesting potential dividend sustainability issues if operational performance deteriorates.
  • Cash reserves of 60.05M provide limited coverage of acquisition spending of (12.37M), which is -4.86x, suggesting aggressive expansion might strain liquidity if market conditions deteriorate.
  • Operating cash flow of 407.57M provides minimal -77.89x coverage of tax expenses of (5.23M), suggesting potential tax planning inefficiencies or unsustainable tax positions.
  • Operating earnings of 179.13M show weak coverage of depreciation charges of 149.84M, with a 1.20 ratio indicating high capital intensity and potential reinvestment needs.

Peer comparison

Companies in the Medical Care Facilities
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 HCA HCA Healthcare, Inc. 114.88 Bn 18.11 1.54 46.35 Bn
2 THC Tenet Healthcare Corp 18.07 Bn 13.34 0.87 13.19 Bn
3 UHS Universal Health Services Inc 14.64 Bn 10.65 0.86 5.11 Bn
4 FMS Fresenius Medical Care AG 14.10 Bn 16.69 0.61 14.98 Bn
5 EHC Encompass Health Corp 12.55 Bn 19.95 2.17 2.66 Bn
6 ENSG Ensign Group, Inc 10.08 Bn 30.72 2.09 2.16 Bn
7 DVA Davita Inc. 8.90 Bn 11.53 0.67 12.78 Bn
8 CHE Chemed Corp 6.38 Bn 22.87 2.52 0.14 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 0.83 1.26
EV to Cash from Ops. EV/CFO 11.53 12.78
EV to Debt EV to Debt 1.69 12.10
EV to EBIT EV/EBIT 26.23 10.74
EV to EBITDA EV/EBITDA 23.79 16.04
EV to Free Cash Flow [EV/FCF] EV/FCF 23.95 18.02
EV to Market Cap EV to Market Cap 2.51 432.64
EV to Revenue EV/Rev 1.19 2.77
Price to Book Value [P/B] P/B 1.11 -1.92
Price to Earnings [P/E] P/E 17.03 5.13
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Div Coverage (Qtr) 2.76 0.10
Dividend Payout Ratio % Div Payout % (Qtr) 36.00 -13.44
Dividend per Basic Share Div per Share (Qtr) 0.31 0.27
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 19.85 5.42
Interest Coverage Int. cover (Qtr) 2.41 -97.94
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) 1.71 -114.65
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) -68.63 65.22
Dividend Growth (1y) % Div 1y % (Qtr) -37.20 0.97
EBIAT Growth (1y) % EBIAT 1y % (Qtr) -50.48 -46.98
EBITDA Growth (1y) % EBITDA 1y % (Qtr) -30.94 75.97
EBIT Growth (1y) % EBIT 1y % (Qtr) -54.13 -61.19
EBT Growth (1y) % EBT 1y % (Qtr) -63.13 -115.48
EPS Growth (1y) % EPS 1y % (Qtr) -59.35 -24.32
FCF Growth (1y) % FCF 1y % (Qtr) -45.02 309.51
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) -6.78 17.88
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.69 1.04
Cash Payout Ratio Cash Payout (Qtr) 0.06 0.04
Cash Ratio Cash Ratio (Qtr) 0.06 0.39
Current Ratio Curr Ratio (Qtr) 1.09 1.39
Debt to Equity Ratio Debt/Equity (Qtr) 1.64 -13.19
Interest Cover Ratio Int Coverage (Qtr) 2.41 -97.94
Times Interest Earned Times Interest Earned (Qtr) 2.41 -97.94
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 8.40 -95.81
EBIT Margin % EBIT Margin % (Qtr) 4.55 -94.97
EBT Margin % EBT Margin % (Qtr) 2.66 -105.60
Gross Margin % Gross Margin % (Qtr) 8.20 23.31
Net Profit Margin % Net Margin % (Qtr) 2.80 -106.14